BRAINLIFE.ORG
|
|
|
|
|
Neuro-Oncology
Reviews
|
|
|
|
Volume
26 Number 22
10 October 2024
|
|
|
|
Home
>
Publications
>
Neuro-Oncology
Reviews >
Volume
26, Year 2024 >
Number 22, 10 October
|
|
|
|
|
|
|
|
Bhardwaj JS, Paliwal S, Singhvi G, Taliyan R.
Immunological
challenges and opportunities
in glioblastoma multiforme: A comprehensive view from immune
system lens.
Life
Sci. 2024 Oct 1;357:123089. doi:
10.1016/j.lfs.2024.123089. PMID:
39362586. Review˰ ˍ
|
|
|
|
Okon II, Osama M, Akpan A, Fabrini Paleare LF, Ferreira MY,
Shafqat MD, Razouqi Y, James E, Omer M, Ja'afar IK, Chaurasia B,
Iqbal M, Balogun S, Maidan A, Hussain Jakhar MO, Precious FK,
Gbayisomore TJ, Lucero-Prisno DE 3rd.
The
Evolving Role of Palliative Care in older people with
Glioblastoma.
World
Neurosurg. 2024 Oct 1:S1878-8750(24)01674-7. doi:
10.1016/j.wneu.2024.09.125. PMID:
39362596. Review˰ ˍ
|
|
|
|
*Alnahhas I.
Molecular Testing in
Gliomas: What is Necessary in Routine Clinical Practice?
Curr
Oncol Rep. 2024 Oct 3. doi:
10.1007/s11912-024-01602-w. PMID:
39361075. Review. ˍ
|
|
|
|
**Magnon C.
What a wonderful world!
Genes
Dev. 2024 Oct 3;38(17-20):802-804. doi:
10.1101/gad.352278.124. PMID:
39362781. Meeting report. ˍ
|
|
|
|
Bourbonne V, Ollivier L, Antoni D, Pradier O, Cailleteau A, Schick
U, Noël G, Lucia F.
Diagnosis and
management of brain radiation necrosis.
Cancer
Radiother. 2024 Oct 4:S1278-3218(24)00141-0. doi:
10.1016/j.canrad.2024.07.014. PMID:
39366819. Review˰ ˍ
|
|
|
|
Jelski W, Mroczko B.
MicroRNAs as
Biomarkers of Brain Tumor.
Cancer
Manag Res. 2024 Oct 4;16:1353-1361. doi:
10.2147/CMAR.S484158. PMID:
39380890. Review. ˍ
|
|
|
|
Karimi-Sani I, Molavi Z, Naderi S, Mirmajidi SH, Zare I,
Naeimzadeh Y, Mansouri A, Tajbakhsh A, Savardashtaki A, Sahebkar
A.
Personalized mRNA vaccines in
glioblastoma therapy: from rational design to clinical trials.
J
Nanobiotechnology. 2024 Oct 4;22(1):601. doi:
10.1186/s12951-024-02882-x. PMID:
39367418. Review. ˍ
|
|
|
|
Cui J, Zou X, Han Y, Jiang J.
Benign
extracranial meningioma with pulmonary metastasis: a case report
and review of literature.
J
Med Case Rep. 2024 Oct 5;18(1):461. doi:
10.1186/s13256-024-04800-z. PMID:
39367495. Case report; Review. ˍ
|
|
|
|
Jiwei B, Abulimiti M, Yonglong J, Jie W, Shuyan Z, Chao L, Zishen
W, Wei W, Yinuo L, Weiwei W, Lu Y, Shimizu S.
Proton
beam therapy in a patient with secondary glioblastoma (32 years
after postoperative irradiation of medulloblastoma): case report
and literature review.
Radiat
Oncol. 2024 Oct 5;19(1):136. doi:
10.1186/s13014-024-02515-5. PMID:
39369243. Case report; Review. ˍ
|
|
|
|
Wen PY, Preusser M, Albert NL.
Design
and conduct of theranostic trials in neuro-oncology: Challenges
and opportunities.
Neuro
Oncol. 2024 Oct 5:noae162. doi:
10.1093/neuonc/noae162. PMID:
39368109. Review. ˍ
|
|
|
|
Bennebroek CA, Montauban van Swijndregt MC, van Zwol J, Bhusal S,
Dittrich AT, Oostenbrink R, Pott JWR, Buijs EA, Schouten-van
Meeteren AY, Porro GL, de Graaf P, Saeed P.
Treatment
of isolated pediatric optic nerve glioma: A nationwide
retrospective cohort study and systematic literature review on
visual and radiological outcome.
Pediatr
Blood Cancer. 2024 Oct 8:e31358. doi:
10.1002/pbc.31358. PMID:
39380191. Observational study; Review. ˍ
|
|
|
|
Levine AB, Hawkins CE.
Molecular
markers for pediatric low-grade glioma.
Childs
Nerv Syst. 2024 Oct 8. doi:
10.1007/s00381-024-06639-7. PMID:
39379532. Review˰ ˍ
|
|
|
|
Lim-Fat MJ, Roberto K, Wen PY.
Clinical
trial design for novel targeted agents in neuro-oncology.
J
Neurooncol. 2024 Oct 8. doi:
10.1007/s11060-024-04846-5. PMID:
39377992. Review˰ ˍ
|
|
|
|
Rathi A, Choudhari AK, Chatterjee A, Sahay A, Bhattacharya K, Sahu
A, Puranik AD, Shah A, Dasgupta A, Gupta T, Epari S.
Spinal
Diffuse Midline Glioma H3K27M-Altered:
Report of a Rare Tumor with Extracranial Skeletal Metastases and
Review of Literature.
Int
J Surg Pathol. 2024 Oct 8:10668969241286243. doi:
10.1177/10668969241286243. PMID:
39376094. Case report; Review˰
ˍ
|
|
|
|
*Sandhanam K, Tamilanban T, Bhattacharjee B, Manasa K.
Exploring
miRNA therapies
and gut microbiome-enhanced CAR-T cells: advancing frontiers in
glioblastoma stem cell targeting.
Naunyn
Schmiedebergs Arch Pharmacol. 2024 Oct 9. doi:
10.1007/s00210-024-03479-9. PMID:
39382681. Review˰ ˍ
|
|
|
|
Stormezand GN, de Meyer E, Koopmans KP, Brouwers AH, Luurtsema G,
Dierckx RAJO.
Update on the Role of
[18F]FDOPA
PET/CT.
Semin
Nucl Med. 2024 Oct 9:S0001-2998(24)00080-1. doi:
10.1053/j.semnuclmed.2024.09.004. PMID:
39384519. Review. ˍ
|
|
|
|
|
|
|
|
*Pan J, Eskandar T, Ahmed Z, Agrawal DK.
Biophysical
and Biological Mechanisms of Tumor Treating Fields in
Glioblastoma.
J
Cancer Sci Clin Ther. 2024 Aug 19;8(3):265-270. doi:
10.26502/jcsct.5079249. PMID:
39364266. Perspective. ˍ
|
|
|
|
Rath S, Shafeea MS, Abdul Hussein AF, Shamil Hashim A, Hassanaien
S, Pastrana-Brandes S, Chaurasia B.
CAR-T-cell
therapy in meningioma: current investigations, advancements and
insight into future directions.
Ann
Med Surg (Lond). 2024 Aug 22;86(10):5957-5965. doi:
10.1097/MS9.0000000000002491. PMID:
39359850. Review. ˍ
|
|
|
|
Paltin I, Sy M, Lundy SM, Ayr-Volta LK, Canale R, Fong G, Janke K,
Pfeifle GB, Quinton T, Schofield HL, Warren EAH.
Neuropsychological Late Effects and
Quality-of-Life Outcomes in Pediatric Brain Tumor Survivors: Role
of Pediatric Neurologists in Monitoring and Management.
Pediatr
Neurol. 2024 Sep 7;161:149-157. doi:
10.1016/j.pediatrneurol.2024.08.014. PMID:
39383589. Review˰ ˍ
|
|
|
|
Sterner RC, Sterner RM.
EGFRVIII and
EGFR targeted chimeric antigen receptor T cell therapy in
glioblastoma.
Front
Oncol. 2024 Sep 19;14:1434495. doi:
10.3389/fonc.2024.1434495. PMID:
39364321. Review. ˍ
|
|
|
|
Saqib M, Zahoor A, Rahib A, Shamim A, Mumtaz H.
Clinical
and translational advances in primary brain tumor therapy with a
focus on glioblastoma-A comprehensive review of the literature.
World
Neurosurg X. 2024 Sep 21;24:100399. doi:
10.1016/j.wnsx.2024.100399.
PMID:
39386927. Review. ˍ
|
|
|
|
Cao S, Wei Y, Yue Y, Wang D, Yang J, Xiong A, Zeng H.
Mapping
the evolution and research landscape of ferroptosis-targeted
nanomedicine: insights from a scientometric analysis.
Front
Pharmacol. 2024 Sep 25;15:1477938. doi:
10.3389/fphar.2024.1477938. PMID:
39386034. Bibliometric analysis. ˍ
|
|
|
|
Mittelbronn M.
Neurooncology: 2024
update.
Free
Neuropathol. 2024 Sep 27;4:21. doi:
10.17879/freeneuropathology-2024-5809. PMID:
39385753. Review. ˍ
|
|
|
|
Wu J, Wang N.
Current progress of
anti-PD-1/PDL1
immunotherapy for glioblastoma
(Review).
Mol
Med Rep. 2024 Sep 30;30(6):221. doi:
10.3892/mmr.2024.13344. PMID:
39364736. Review.
ˍ
|
|
|
|
|
|
|
|
|
|
|
|
|